Get more replies from employers
Send a job-specific resume in minutes.
Aspire Life Sciences Search seeks a founding-level hire to lead drug discovery from idea to first in human. This role offers ownership over therapeutic programmes and pivotal involvement in shaping the company's scientific and operational foundations.
The ideal candidate has a strong biological background, excels in ambiguity, and is interested in modern AI-driven biology. This is an opportunity to work closely with a founding team aiming to redefine biotech.
Have you ever wanted to take full ownership of a drug discovery programme, from initial idea through to first in human?
This is an opportunity to join a venture-backed, AI native biotech at the earliest stage and play a central role in shaping how programmes are built, prioritised and advanced. You will not be inheriting a function. You will be helping define it.
Our client is building a new type of biotech. A small, high agency team focused on developing novel therapies for diseases with limited treatment options, using a combination of modern AI-enabled biology and a highly leveraged external model.
Rather than scaling large internal teams, they partner with best-in-class computational and wet lab CROs, allowing them to run multiple programmes in parallel while staying lean and focused. The founding team brings deep expertise in AI-driven biology and early discovery, with an ambition to build a new generation of virtual biotech capable of moving quickly from idea to clinical validation.
This is a founding-level hire, intentionally broad in scope and high in impact. You will operate across the full lifecycle of drug discovery and early development, with real ownership of programmes rather than a narrow functional remit.
Key responsibilities include:
You will also play a role in company building, from engaging external experts to selecting tools and shaping how work gets done.
There is no single background that defines the right profile. This could suit:
This is not a typical hire into an established structure. It is an opportunity to shape both the science and the way the company operates, working closely with a founding team that is already thinking differently about how biotech should be built.